WGU D027 STUDY GUIDE EXAM QUESTIONS AND CORRECT
ANSWERS GRAIDED A+
normal ejection fraction - ASNWER-55 - 60 % (blood pumped out with each
heartbeat)
Ejection fraction of 50% - reduced or preserved? - ASNWER-preserved
Diastolic CHF - ASNWER-preserved ejection fraction, problem is with filling
Systolic CHF - ASNWER-reduced ejection fraction, problem is with ejecting
Left sided CHF - ASNWER-pulmonary (JVD, fluid volume overload, rails, S-3
murmurs) ** #1 cause of Right sided CHF
BNP - ASNWER-gold standard lab test to diagnose CHF
,Klinefelter Syndrome (XXY) - ASNWER-male has extra X, female like qualities
Turner Syndrome - ASNWER-Missing X in females
Alpha Thalassemia - ASNWER-inherited blood disorder; mild to severe anemia
Beta Thallasemia - ASNWER-low hemoglobin; contraindicated medication ferrous
sulfate
Prevalence Risk - ASNWER-proportion of the population affected at a certain time
Incidence rate - ASNWER-number of new cases divided by population
Innate immunity - ASNWER-inflammation; increased vascular permeability
B&T lymphocytes - ASNWER-immune response
primary malignant tumor - ASNWER-lack of organization of cells
glucocorticoids - ASNWER-used in combination with other agent to treat lymphoid
tissue (leukemia). glucocorticoids are directly toxic to lymphoid tissues.
Selective estrogen receptor modulators (SERM) - ASNWER-for hormone receptor
positive and advanced breast cancer. (Tamoxifin reduces risk and recurrence risk)
, Heart failure - ASNWER-impairment of the ventricle to fill with or eject blood;
heart cannot meet metabolic need of the body.
CHF - ASNWER-heart cannot keep up with metabolic needs; volume overload in
pulmonary area
Echocardiogram - ASNWER-Diagnostic tool, evaluates heart structure and function
At Risk for HF - Stage A - ASNWER-no structural heart disease or symptoms of
heart failure
Stage A HF co-morbidities - ASNWER-htn, atherosclerotic disease, diabetes,
metabolic syndrome, patients using cardiotoxins with family history
Therapy goals of stage A HF - ASNWER-treat htn, encourage smoking cessation,
encourage regular exercise, treat lipid disorders, discourage alcohol intake/drug
use, control metabolic syndrome
Meds: ACEI or Angiotensin II RB for vascular disease or diabetes (avapro, losartan,
benicar, diovan, etc)
At Risk for HF - Stage B - ASNWER-structural heart disease but no symptoms of
heart failure
Stage B HF co-morbidities - ASNWER-previous MI, LV remodeling with LV
hypertrophy and low EF, asymptomatic valvular disease
ANSWERS GRAIDED A+
normal ejection fraction - ASNWER-55 - 60 % (blood pumped out with each
heartbeat)
Ejection fraction of 50% - reduced or preserved? - ASNWER-preserved
Diastolic CHF - ASNWER-preserved ejection fraction, problem is with filling
Systolic CHF - ASNWER-reduced ejection fraction, problem is with ejecting
Left sided CHF - ASNWER-pulmonary (JVD, fluid volume overload, rails, S-3
murmurs) ** #1 cause of Right sided CHF
BNP - ASNWER-gold standard lab test to diagnose CHF
,Klinefelter Syndrome (XXY) - ASNWER-male has extra X, female like qualities
Turner Syndrome - ASNWER-Missing X in females
Alpha Thalassemia - ASNWER-inherited blood disorder; mild to severe anemia
Beta Thallasemia - ASNWER-low hemoglobin; contraindicated medication ferrous
sulfate
Prevalence Risk - ASNWER-proportion of the population affected at a certain time
Incidence rate - ASNWER-number of new cases divided by population
Innate immunity - ASNWER-inflammation; increased vascular permeability
B&T lymphocytes - ASNWER-immune response
primary malignant tumor - ASNWER-lack of organization of cells
glucocorticoids - ASNWER-used in combination with other agent to treat lymphoid
tissue (leukemia). glucocorticoids are directly toxic to lymphoid tissues.
Selective estrogen receptor modulators (SERM) - ASNWER-for hormone receptor
positive and advanced breast cancer. (Tamoxifin reduces risk and recurrence risk)
, Heart failure - ASNWER-impairment of the ventricle to fill with or eject blood;
heart cannot meet metabolic need of the body.
CHF - ASNWER-heart cannot keep up with metabolic needs; volume overload in
pulmonary area
Echocardiogram - ASNWER-Diagnostic tool, evaluates heart structure and function
At Risk for HF - Stage A - ASNWER-no structural heart disease or symptoms of
heart failure
Stage A HF co-morbidities - ASNWER-htn, atherosclerotic disease, diabetes,
metabolic syndrome, patients using cardiotoxins with family history
Therapy goals of stage A HF - ASNWER-treat htn, encourage smoking cessation,
encourage regular exercise, treat lipid disorders, discourage alcohol intake/drug
use, control metabolic syndrome
Meds: ACEI or Angiotensin II RB for vascular disease or diabetes (avapro, losartan,
benicar, diovan, etc)
At Risk for HF - Stage B - ASNWER-structural heart disease but no symptoms of
heart failure
Stage B HF co-morbidities - ASNWER-previous MI, LV remodeling with LV
hypertrophy and low EF, asymptomatic valvular disease
